NON-FINAL ACTION - MAILED
final action
on 27 Jun 2024
Last Applicant/ Owned by
DK-2730 Herlev
DK
Serial Number
79392510 filed on 19th Sep 2023
Registration Number
N/A
Correspondent Address
DK-1411 Copenhagen K,
DENMARK
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
RHEUMATRACE
Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tiss Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis for medical and pharmaceutical research services; advice, information and assistance relating to the foregoing
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Diagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations, substances and materials; medical diagnostic test strips; diagnostic preparations for medical purposes; diagnostic agents for medical use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79392510
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 15th Jul 2024 | REFUSAL PROCESSED BY IB |
| 27th Jun 2024 | REFUSAL PROCESSED BY MPU |
| 27th Jun 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 14th Jun 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 31st May 2024 | NON-FINAL ACTION WRITTEN |
| 13th May 2024 | ASSIGNED TO EXAMINER |
| 05th Apr 2024 | APPLICATION FILING RECEIPT MAILED |
| 01st Apr 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 28th Mar 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |